This website is in beta version
Projects
ESC Atlas of Cardiology
ESC Atlas in Heart Failure
ESC Atlas in Interventional Cardiology
Burden of Cardiovascular Disease
Countries
Data
National sociodemographic characteristics
Economic and health expenditure
Risk factors
Cardiovascular disease morbidity
Cardiovascular disease mortality
Cardiovascular healthcare delivery
Publications
About
Contact
MENU
Cardiovascular healthcare delivery data variables
Click on the category to get a list of all variables within that category
No results found.
Cardiological specialists
Cardiac surgeons (per million people)
Cardiologists (total) (per million people)
Cardiologists, females (% of cardiologists, total)
Interventional cardiologists (per million people)
Interventional cardiologists performing transcatheter valvular heart disease interventions (per million people)
Interventional cardiology operators in training (from your own country) (per million people)
Total cardiac surgeons (females) (% of cardiac surgeons, total)
Total interventional cardiologists (females) (% of interventional cardiologists, total)
Diagnostic coronary angiography
Coronary angiography and diagnostic cardiac catheterization (per million people)
Electrophysiology
Ablations of atrial focal tachycardia, AV nodal tachycardias and ablations of atrio-ventricular bypass tract tachycardia (per million people)
Ablations of ventricular tachycardia (per million people)
Ablations to correct heart rhythm disorders (per million people)
Atrial fibrillation and/or atrial flutter ablations in female patients (% of all ablations)
Cardiac resynchronization therapy device (CRT-D and CRT-P) implantations (per million people)
Hospitals implanting cardiac resynchronization therapy (CRT) devices (per million people)
Hospitals implanting cardioverter defibrillators (ICDs) (per million people)
Hospitals implanting pacemakers (per million people)
Hospitals undertaking electrophysiology procedures (per million people)
Implantable cardioverter defibrillator (ICD) implantations (per million people)
Implantable cardioverter defibrillator (ICD) implantations in female patients (% of all ICD implantations)
Pacemaker implantations (per million people)
Pacemaker implantations in female patients (% of all pacemaker implantations)
Interventional cardiology infrastructure
Hospital with cath labs (per million people)
Hospitals performing TAVI without on-site cardiac surgery (per million people)
Hospitals with cath labs and on-site cardiac surgery (per million people)
Hospitals with cath labs on 24 hours/7 days service (per million people)
Hospitals with cath labs performing TAVI (per million people)
Hospitals with cath labs performing structural heart disease interventions in children (per million people)
Hospitals with cath labs performing structural heart disease interventions in the adult (per million people)
Public hospitals with cardiac cath labs (per million people)
Total cath labs (per million people)
Total number of hybrid catheterisation rooms (per million people)
Interventional cardiology procedures
Acute ischemic stroke interventions (per million people)
Adjunctive intracoronary imaging techniques (per million people)
Adjunctive intracoronary physiology measurements (per million people)
Alcohol septum ablations (per million people)
Aortic balloon valvuloplasties (per million people)
Atrial septum closures (per million people)
Coronary bio-resorbable vascular scaffolds (per million people)
Coronary drug-eluting stents (per million people)
Coronary stents (per million people)
Impella devices for heart failure (per million people)
Intervention for acute pulmonary embolism (per million people)
Intervention for chronic pulmonary hypertension (per million people)
Left atrial appendage occlusions (per million people)
Mitral balloon valvuloplasties (per million people)
Non-femoral transcatheter aortic valve implantations (per million people)
Percent of percutaneous coronary interventions (PCI) performed by trans-radial access
Percutaneous aortic valve implantation (TAVI) (per million people)
Percutaneous coronary interventions (PCI) (per million people)
Percutaneous coronary interventions (PCI) for in-stent restenosis (per million people)
Percutaneous coronary interventions (PCI) in coronary artery with chronic total occlusions (CTO) (per million people)
Percutaneous coronary interventions (PCI) in female patients (% of all PCI)
Percutaneous coronary interventions (PCI) in unprotected left main (LM) coronary artery (per million people)
Percutaneous coronary interventions (PCI) performed with adjunctive intracoronary imaging techniques (per million people)
Percutaneous coronary interventions (PCI) performed with adjunctive intracoronary physiology measurements (per million people)
Percutaneous coronary interventions (PCI) with bio-resorbable vascular scaffolds (per million people)
Percutaneous coronary interventions (PCI) with coronary stents (per million people)
Percutaneous coronary interventions (PCI) with drug-eluting balloons (per million people)
Percutaneous coronary interventions (PCI) with drug-eluting coronary stents (per million people)
Percutaneous coronary interventions (PCI) with intravascular lithotripsy (IVL) (per million people)
Percutaneous coronary interventions (PCI) with rotational or orbital atherectomy (per million people)
Percutaneous coronary interventions (PCI) without stent (per million people)
Percutaneous mitral valve interventions (per million people)
Percutaneous tricuspid valve interventions (per million people)
Peri-valvular leaks closures (per million people)
Primary percutaneous coronary intervention (pPCI) (per million people)
Primary percutaneous coronary intervention (pPCI) in female patients (% of all pPCI)
Procedures with cerebral embolic protection devices (per million people)
TAVI for pure aortic regurgitation (per million people)
TAVI performed in native aortic valve (excluding valve in valve) (per million people)
Transapical transcatheter aortic valve implantations (per million people)
Transcatheter aortic valve implantation (TAVI) in female patients (% of all TAVI)
Transcatheter aortic valve-in-valve implantations in previous TAVIs (per million people)
Transcatheter aortic valve-in-valve implantations in surgical valve (per million people)
Transcatheter interventions for congenital heart disease in adults (per million people)
Transcatheter mitral valve in valve implantation with TAVI device (per million people)
Transcatheter mitral valve interventions in female patients (% of all mitral interventions)
Transcatheter native mitral valve repairs (per million people)
Transcatheter native mitral valve replacement (per million people)
Transcatheter tricuspid valve repairs (per million people)
Transcatheter tricuspid valve replacement (per million people)
Transfemoral transcatheter aortic valve implantations (per million people)
Transvascular transcatheter aortic valve implantations (per million people)
Use of hemodynamic support devices (per million people)
Valve-in-valve percutaneous implantations (per million people)
Ventricular septum closures (per million people)
Heart failure health care
Average length of stay in hospital primarily due to HF
Cardiac MRI units (per million people)
Cardiology departments performing device-based decongestion therapy (per million people)
Hospitals implanting Mitraclip (per million people)
Hospitals implanting left ventricular assist devices (LVAD) (per million people)
Hospitals performing HF exercise programs for HF patients (per million people)
Hospitals performing spiro-ergometry (per million people)
Hospitals with advanced ultrasound imaging (per million people)
Hospitals with availability to obtain BNP (NT-proBNP) in ER (per million people)
Hospitals with dedicated HF centers (per million people)
Number of HF-related hospital discharges (per million people)
Palliative care units for patients with advanced/end-stage HF (per million people)
Cardiac surgery
Coronary artery bypass graft surgery (CABG) in female patients (% of all CABG)
ECMO for heart failure (per million people)
Heart transplantations (per million people)
Left ventricular assist device implantations for acute and/or chronic heart failure (per million people)
Left, right and both ventricular assist device implantations (per million people)
Surgical aortic valve procedures (repairs and replacements) in female patients (% of all procedures)
Surgical interventions in congenital heart disease (per million people)
Surgical mitral valve procedures (repairs and replacements) (per million people)
Surgical tricuspid valve procedures (repairs and replacements) (per million people)
Congenital heart disease
Hospitals undertaking congenital heart disease surgery (per million people)
Percutaneous procedures for congenital heart disease (per million people)
Cardiac Capital Resources
Hospitals with cardiac rehabilitation programmes (per million people)
Hospitals with dedicated coronary care units (per million people)
Hospitals with dedicated stroke units (per million people)